癌症疼痛藥物市場規模、佔有率和成長分析（按藥物類別、適應症、通路、給藥途徑、最終用戶和地區分類）—2026-2033年產業預測

全球癌症疼痛治療市場規模預計在 2024 年達到 79.2 億美元，從 2025 年的 83.6 億美元成長到 2033 年的 129.3 億美元，在預測期（2026-2033 年）內複合年成長率為 5.6%。

全球癌症疼痛市場正經歷顯著成長，其主要促進因素包括癌症發生率上升、人口老化、醫療保健投資增加以及醫療機構研發投入的增加。隨著各種癌症發病率的上升，尤其是老年族群（他們更容易受到老齡化相關變化和遺傳因素的影響），對有效疼痛管理解決方案的需求持續成長。目前，各種癌症（特別是大腸直腸癌、乳癌、肺癌和攝護腺癌）的診斷年齡呈現提前趨勢。這一趨勢凸顯了癌症治療中全面疼痛緩解策略的緊迫性，推動了市場擴張，並反映出腫瘤治療領域對患者生活品質（QOL）日益成長的關注。

全球癌症疼痛管理市場促進因素

透過開發創新技術、改進藥物輸送系統和製定個人化治療方案，科技進步顯著改善了癌症患者的疼痛管理。這些突破性進展有助於提供更有效的止痛方案，並改善患者獲得適當照護的機會。隨著新方法的出現，癌症相關疼痛的複雜性得以解決，使醫療專業人員能夠提供更有針對性和更有效的策略。該領域的持續進步不僅提高了護理標準，而且透過為患者提供個人化的疼痛管理方案，增強了患者的自主權，最終改善了他們的整體生活品質。

限制全球癌症疼痛市場的因素

全球癌症疼痛市場面臨許多挑戰，可能阻礙其擴張，尤其是在藥物抗藥性和依賴性以及止痛藥物的各種副作用方面。這些擔憂可能導致醫護人員和患者在開立或使用這些藥物時猶豫不決。因此，對長期用藥風險的認知可能會促使人們更加謹慎地檢視和使用藥物。此外，持續監測和調整治療方案的需求可能會使管理策略複雜化，影響市場的整體成長軌跡，並可能影響患者獲得有效止痛方案的機會。

全球癌症疼痛治療市場趨勢

全球癌症疼痛市場正加速朝向個人化疼痛管理策略發展，強調根據患者獨特的基因和分子特徵量身定做的個人化治療方案。這一轉變反映了醫療保健領域更廣泛的趨勢，即透過提高治療效果和減少副作用來改善患者預後。基因組學和分子生物學的持續進步正推動醫療服務提供者採用更先進的調查方法來評估和管理癌症相關疼痛，從而促進以患者為中心的護理模式的形成。這種對個人化治療的關注不僅提高了患者的生活品質，也推動了製藥和醫療設備業的創新。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管分析
• 技術分析

全球癌症疼痛治療市場規模（按藥物類別和複合年成長率分類）（2026-2033 年）

• 鴉片類藥物
• 羥考酮
• 氫可酮
• 非類固醇消炎劑（NSAIDs）
• Ibuprofen
• 萘普生
• 其他

全球癌症疼痛治療市場規模（按適應症和複合年成長率分類）（2026-2033 年）

• 肺癌
• 大腸直腸癌
• 乳癌
• 攝護腺癌
• 血癌
• 其他

全球癌症疼痛治療市場規模（按分銷管道分類）及複合年成長率（2026-2033 年）

• 醫院藥房
• 網路藥房
• 零售藥房

全球癌症疼痛治療市場規模（按給藥途徑和複合年成長率分類）（2026-2033 年）

• 口服
• 腸外
• 其他

全球癌症疼痛治療市場規模（按最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院
• 居家醫療
• 專科診所
• 其他

全球癌症疼痛治療市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Pfizer（USA）
• Johnson & Johnson（USA）
• Purdue Pharma（USA）
• Novartis（Switzerland）
• Heron Therapeutics（USA）
• Teva Pharmaceutical Industries（Israel）
• Eli Lilly and Company（USA）
• AstraZeneca（UK）
• GlaxoSmithKline（UK）
• Merck & Co., Inc.（USA）

結論與建議

Global Cancer Pain Market size was valued at USD 7.92 Billion in 2024 and is poised to grow from USD 8.36 Billion in 2025 to USD 12.93 Billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026-2033).

The global cancer pain market is experiencing significant growth driven by several key factors, including the rising incidence of cancer, an aging demographic, increased healthcare investments, and intensified research and development initiatives by healthcare organizations. As the prevalence of different cancer types escalates, particularly among older adults who are more vulnerable to age-related changes and genetic predispositions, the demand for effective pain management solutions continues to rise. Notably, various cancers, including colorectal, breast, lung, and prostate, showcase a trend where early diagnosis often occurs at advanced ages. This highlights the urgent need for comprehensive pain relief strategies in cancer care, supporting the market's expansion while also reflecting the growing focus on patient quality of life in oncology.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cancer Pain market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cancer Pain Market Segments Analysis

Global Cancer Pain Market is segmented by Drug Class, Indication, Distribution Channel, Route of Administration, End User and region. Based on Drug Class, the market is segmented into Opioids, Oxycodone, Hydrocodone, NSAIDs, Ibuprofen, Naproxen and Others. Based on Indication, the market is segmented into Lung cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Blood Cancer and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Online Pharmacy and Retail Pharmacy. Based on Route of Administration, the market is segmented into Oral, Parenteral and Others. Based on End User, the market is segmented into Hospitals, Homecare, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cancer Pain Market

Advancements in technology significantly improve pain management for cancer patients through the development of innovative techniques, enhanced drug delivery systems, and tailored treatment options. These breakthroughs contribute to more effective pain relief solutions, ultimately increasing accessibility for patients seeking appropriate care. As new methods emerge, they address the complexities of cancer-related pain, allowing healthcare professionals to offer more targeted and effective strategies. This ongoing evolution in the field not only elevates the standard of care but also empowers patients by providing them with personalized approaches to managing their pain, thereby improving their overall quality of life.

Restraints in the Global Cancer Pain Market

The Global Cancer Pain market faces challenges that may inhibit its expansion, particularly concerning the potential for drug tolerance, dependence, and a range of side effects related to pain medications. These concerns can create hesitancy among healthcare providers and patients when it comes to prescribing or using these treatments. Consequently, the perception of risks associated with long-term medication use may lead to increased scrutiny and caution. Additionally, the need for ongoing monitoring and adjustment of treatment plans can complicate management strategies, thereby influencing the overall growth trajectory of the market and impacting patient access to effective pain relief solutions.

Market Trends of the Global Cancer Pain Market

The Global Cancer Pain market is increasingly trending towards personalized pain management strategies, emphasizing individualized treatment approaches tailored to patients' unique genetic and molecular profiles. This shift reflects a broader movement within the healthcare sector to enhance therapeutic efficacy and minimize side effects, ultimately improving patient outcomes. As advancements in genomics and molecular biology continue to emerge, healthcare providers are adopting more precise methodologies to assess and address cancer-related pain, fostering a more patient-centric model of care. This focus on personalized treatment not only enhances the quality of life for patients but also drives innovation within the pharmaceutical and medical device industries.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Analysis
• Technology Analysis

Global Cancer Pain Market Size by Drug Class & CAGR (2026-2033)

• Market Overview
• Opioids
• Oxycodone
• Hydrocodone
• NSAIDs
• Ibuprofen
• Naproxen
• Others

Global Cancer Pain Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Lung cancer
• Colorectal Cancer
• Breast Cancer
• Prostate Cancer
• Blood Cancer
• Others

Global Cancer Pain Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Global Cancer Pain Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Parenteral
• Others

Global Cancer Pain Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Homecare
• Specialty Clinics
• Others

Global Cancer Pain Market Size & CAGR (2026-2033)

• North America (Drug Class, Indication, Distribution Channel, Route of Administration, End User)
  • US
  • Canada
• Europe (Drug Class, Indication, Distribution Channel, Route of Administration, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Drug Class, Indication, Distribution Channel, Route of Administration, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Drug Class, Indication, Distribution Channel, Route of Administration, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Drug Class, Indication, Distribution Channel, Route of Administration, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pfizer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Purdue Pharma (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heron Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations